R.B.Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
as on 02-01-2025
- Paid Up Capital ₹ 0.30 M
as on 02-01-2025
- Company Age 19 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.45 M
as on 02-01-2025
- Satisfied Charges ₹ 1.50 M
as on 02-01-2025
- Revenue 3.59%
(FY 2022)
- Profit -0.71%
(FY 2022)
- Ebitda -6.34%
(FY 2022)
- Net Worth 11.59%
(FY 2022)
- Total Assets 2.27%
(FY 2022)
About R.B.Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹5.45 M. The company has closed loans amounting to ₹1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Neelam Ujjawalkumar and Ujjwal Shrivastav serve as directors at the Company.
- CIN/LLPIN
U24230GJ2006PTC047463
- Company No.
047463
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationNa, Gujarat
- Telephone
- Email Address
- Website
- Social Media-
What products or services does R.B.Remedies Private Limited offer?
R.B.Remedies Private Limited offers a wide range of products and services, including Pain Reliever Gel, Diclofenac Diethylamine Gel, Allopathic Cough Syrup, Guaiphenesin Cough Syrup, Common Disease Medicines, Pharmaceutical Capsules, Anti Inflammatory Drugs, Methylprednisolone Tablet, Cough Syrup, Antacid Drugs.
Who are the key members and board of directors at R.B.Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujjwal Shrivastav  | Director | 06-Jan-2006 | Current |
| Neelam Ujjawalkumar | Director | 06-Jan-2006 | Current |
Financial Performance of R.B.Remedies.
R.B.Remedies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.59% increase. The company also saw a slight decrease in profitability, with a 0.71% decrease in profit. The company's net worth Soared by an impressive increase of 11.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.B.Remedies?
In 2022, R.B.Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Durotech Air System Pprivate LimitedActive 19 yearsNeelam Ujjawalkumar and Ujjwal Shrivastav are mutual person
- Lotus Airtech Private LimitedActive 15 years 1 month
Neelam Ujjawalkumar and Ujjwal Shrivastav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Feb 2014 | ₹5.45 M | Open |
State Bank Of India Creation Date: 25 Jul 2011 | ₹1.50 M | Satisfied |
How Many Employees Work at R.B.Remedies?
Unlock and access historical data on people associated with R.B.Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.B.Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.B.Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
